Biomerica (BMRA) Cash from Operations (2010 - 2026)

Biomerica has disclosed Cash from Operations across 17 years of filings, most recently posting 1250000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 1250000.0, down 19.62% year-over-year; the trailing twelve-month figure through Feb 2026 was 3170000.0 (up 24.95% YoY), and the FY2025 annual result was 3841000.0, up 28.35% from the prior year.
• Cash from Operations came in at 1250000.0 for Q1 2026 at Biomerica, down from 991000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 2358296.0 in Q1 2022 to a low of 4256046.0 in Q2 2022.
• The 5-year median for Cash from Operations is 1045000.0 (2025), against an average of 1122514.71.
• Peak annual rise in Cash from Operations reached 272.92% in 2022, while the deepest fall reached 2174.21% in 2022.
• Biomerica's Cash from Operations stood at 1213000.0 in 2022, then soared by 30.59% to 842000.0 in 2023, then increased by 6.06% to 791000.0 in 2024, then fell by 25.28% to 991000.0 in 2025, then dropped by 26.14% to 1250000.0 in 2026.
• The last three Cash from Operations figures came in at 1250000.0 (Q1 2026), 991000.0 (Q4 2025), and 268000.0 (Q3 2025), per Business Quant data.